Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Former EVP, CFO, & Director

EVP & CFO

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need in oncology. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201 for lung injury caused by cancer treatment. In addition, the company develops immunotherapy/chimeric antigen receptor therapy programs. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-10	Premium	bought	Premium	Premium	Premium	-
2023-11-15	Premium	sold	Premium	Premium	Premium	Former EVP, CFO, & Director
2023-06-20	Premium	bought	Premium	Premium	Premium	EVP & CFO
2021-07-02	Premium	acquired	Premium	Premium	Premium	-
2021-07-02	Premium	sold	Premium	Premium	Premium	-
2021-07-02	Premium	sold (taxes)	Premium	Premium	Premium	-

ATOS - Atossa Genetics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ATOS